全文获取类型
收费全文 | 1070篇 |
免费 | 87篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 43篇 |
妇产科学 | 5篇 |
基础医学 | 92篇 |
口腔科学 | 26篇 |
临床医学 | 112篇 |
内科学 | 311篇 |
皮肤病学 | 8篇 |
神经病学 | 65篇 |
特种医学 | 70篇 |
外科学 | 209篇 |
综合类 | 57篇 |
一般理论 | 1篇 |
预防医学 | 48篇 |
眼科学 | 13篇 |
药学 | 59篇 |
肿瘤学 | 51篇 |
出版年
2023年 | 6篇 |
2022年 | 11篇 |
2021年 | 25篇 |
2020年 | 18篇 |
2019年 | 16篇 |
2018年 | 37篇 |
2017年 | 13篇 |
2016年 | 21篇 |
2015年 | 18篇 |
2014年 | 24篇 |
2013年 | 47篇 |
2012年 | 66篇 |
2011年 | 45篇 |
2010年 | 30篇 |
2009年 | 33篇 |
2008年 | 53篇 |
2007年 | 69篇 |
2006年 | 50篇 |
2005年 | 31篇 |
2004年 | 41篇 |
2003年 | 29篇 |
2002年 | 44篇 |
2001年 | 38篇 |
2000年 | 32篇 |
1999年 | 28篇 |
1998年 | 38篇 |
1997年 | 30篇 |
1996年 | 25篇 |
1995年 | 14篇 |
1994年 | 25篇 |
1993年 | 17篇 |
1992年 | 16篇 |
1991年 | 19篇 |
1990年 | 12篇 |
1989年 | 24篇 |
1988年 | 27篇 |
1987年 | 16篇 |
1986年 | 19篇 |
1985年 | 18篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 9篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1973年 | 2篇 |
1970年 | 2篇 |
1963年 | 2篇 |
排序方式: 共有1184条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
The present study in the anesthetized dogs was designed to test the hypothesis that atrial natriuretic factor (ANF) attenuates whole kidney tubuloglomerular feedback (TGF) mediated decreases in renal blood flow (RBF) and glomerular filtration rate (GFR) produced by hypertonic saline (HS). Secondly, as adenosine (AD) has been implicated as a metabolic mediator of TGF, we also hypothesized that ANF would antagonize the renal actions of AD. To test this hypothesis, RBF and GFR were assessed in response to hypertonic saline (HS, 16%, i.r.) or adenosine (AD, 0.1 mumol/min, i.r.) in the presence and absence of exogenous ANF (100 ng/kg/min, i.r.). ANF attenuated HS-mediated reductions in GFR (HS, -39.6 +/- 9.8 ml/min vs. HS + ANF, -14.3 +/- 4.5 ml/min, P less than 0.05) and in RBF (HS, -143 +/- 35 ml/min vs. HS + ANF, -5 +/- 22 ml/min, P less than 0.05). GFR was reduced by AD (-9.2 +/- 3.0 ml/min, P less than 0.05), but maintained by AD + ANF (-0.4 +/- 2.0 ml/min, NS). A transient adenosine-mediated vasoconstriction was attenuated by ANF (AD, -54.5 +/- 3.6 ml/min vs. AD + ANF, -3.7 +/- 3.1 ml/min, P less than 0.005). We conclude that ANF at pharmacologic concentrations attenuates at the whole kidney level hypertonic saline and adenosine-mediated reductions in RBF and GFR. 相似文献
5.
6.
CG Teo 《Oral diseases》2002,8(S2):88-90
Oral hairy leukoplakia (OHL) and Kaposi's sarcoma (KS) are commonly encountered in the HIV-infected patient. A unique feature of OHL is non-cytolytic high level of replication of Epstein–Barr virus (EBV) in the glossal epithelium. The expression of viral-encoded anti-apoptotic proteins concomitant to replicative proteins probably underlies this phenomenon. The question of whether OHL arises from activation of EBV latent in the tongue, or from superinfection by endogenous EBV shed via non-glossal sites or by exogenous EBV remains unresolved. Human herpesvirus 8 (HHV8) is now seen as necessary but not sufficient cause of KS. Expression of HHV8-encoded oncogenic proteins in endothelial cells probably explains the aberrant proliferation of these cells in KS lesions. Studies into why KS is so commonly observed at the palate in HIV-infected patients may provide important clues to its pathogenesis. 相似文献
7.
Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage 总被引:3,自引:0,他引:3
E S Flamm H P Adams D W Beck R S Pinto J R Marler M D Walker J C Godersky C M Loftus J Biller D J Boarini 《Journal of neurosurgery》1988,68(3):393-400
A dose-escalation study of the calcium ion entry blocking drug nicardipine was performed using large dose infusions in 67 patients with recent aneurysmal subarachnoid hemorrhage (SAH). A safe, potentially therapeutic dose of the drug was determined. Patients admitted within 7 days of SAH from a documented cerebral aneurysm were entered into the study if no spasm was present on the initial angiogram. Nicardipine was administered as a continuous intravenous infusion throughout the 14-day period after SAH, regardless of the timing of surgery. To determine the safest possible dose, nicardipine was administered at seven dose levels from 0.01 to 0.15 mg/kg/hr. The total daily doses ranged from 27.7 mg to 375.0 mg. A follow-up angiogram was carried out on all 67 patients 7 to 10 days after SAH. Computerized tomography and neurological examinations were used to determine the presence of cerebral infarction. No major adverse effects, unexpected reactions, or permanent sequelae could be attributed to nicardipine. A decline in blood pressure was noted following administration of the drug. This occurred more frequently among patients given the largest dose but did not produce clinical problems or require discontinuation of the drug. Favorable outcomes were noted in 52 patients (78%). Vasospasm was found by arteriography in 31 patients (46%). A dose-related trend was noted: only eight (24%) of 33 patients treated at the highest dose level (approximately 10 mg/hr) developed arteriographic evidence of vasospasm. Symptomatic vasospasm was diagnosed in only two (6%) of 33 patients treated with this dose. Of the 34 patients receiving the lower dose levels, angiographic spasm was observed in 68% and symptomatic vasospasm in 27%. No deaths due to vasospasm occurred. Nicardipine appears to prevent both vasospasm and cerebral ischemia after SAH. A multicenter randomized double-blind trial to test this hypothesis is planned. 相似文献
8.
9.
10.
We have isolated plasma cell hybridomas which secrete monoclonal antibodies directed against Haemophilus ducreyi. Two of these monoclonal antibodies recognize all strains of H. ducreyi tested to date and are capable of detecting the presence of H. ducreyi in skin lesions produced by this pathogen in experimental animals. These monoclonal antibodies which react with apparently all strains of H. ducreyi have the potential to be developed into a rapid immunodiagnostic test for chancroid. 相似文献